30 Day Survival Rates Following Congenital Heart Disease Surgery Published Today
The National Congenital Heart Disease Audit (NCHDA) has today published the 2011/14 annual analysis. The findings are based on data submitted by combined 14 paediatric and 20 centres who only undertake procedures in adults with congenital heart disease. This covers all NHS and private paediatric and congenital heart disease procedures undertaken at centres in the UK and Republic of Ireland. Analyses are based on 31,511 paediatric and congenital heart surgery and interventions undertaken between April 1st 2011 and March 31st 2014.
- Survival at 30-days after each of the 56 surgical and transcatheter cardiovascular interventions most frequently undertaken to treat congenital heart disease in children, young people and adults continues to be within the appropriate limits and not below the red alert limit.
- For the 56 specific procedures used as a basis of inter‐unit comparison, there was one warning level outliers for paediatric cardiac surgery at a single centre and none for paediatric intervention, adult congenital heart disease (ACHD) surgery and ACHD intervention. The hospital concerned has been contacted by NICOR and the relevant professional societies, and the centre’s response is available on the NCHDA portal.
- Analysis of the 30 day post procedural outcomes for all hospitals shows an upward trend in survival in the most recent 18 months. The overall 30 day survival for all congenital heart disease procedures is extremely high and indeed one of the highest reported anywhere in the world.
- Antenatal diagnosis of congenital heart disease has gradually improved over the past 8 years. In 2013/14, approaching 45% of infants who required a procedure to treat a congenital heart malformation in the first year of life were diagnosed through antenatal screening, compared to less than a quarter of cases in 2003/4.
To download the Annual Report and reports from previous years please go to this page: